E-Mindfulness Approaches for Living After Breast Cancer
for Breast Cancer
332 locations incl. Phoenix
Sponsor: NRG Oncology
Sex: All·Age: 18 - 50
Code: NCT06748222·Phase 3·Recruiting
Women's health Clinical Trials in New York, NY
As of June 2026, 192 paid clinical trials are recruiting for Women's health in New York, New York. Recruiting Women's health studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
192 clinical trials for Women's health
·Clear filters·↓ Download CSVA Study of Revaree Plus in People With Breast Cancer
for Breast Cancer
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female·Age: 18+
Code: NCT07042581·Phase 4·Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
for Endometrial Cancer
7 locations incl. Washington D.C.
Sponsor: BioNTech SE
Sex: Female·Age: 18+
Code: NCT06340568·Phase 3·Recruiting
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
for Diabetes, Gestational
5 locations incl. Santa Barbara
Sponsor: Jaeb Center for Health Research
Sex: Female·Age: 18 - 40
Code: NCT06535789·Phase 2, Phase 3·Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for Endometrial Cancer
44 locations incl. Mobile
Sponsor: Merck Sharp & Dohme LLC
Sex: Female·Age: 18+
Code: NCT06952504·Phase 3·Recruiting
SLV-154 Treatment of Metastatic Solid Tumors
for Squamous Cell Cancer of Head and Neck (SCCHN)
9 locations incl. Newport Beach
Sponsor: Solve Therapeutics
Sex: All·Age: 18+
Code: NCT06771219·Phase 1·Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
for Cervical Cancer
92 locations incl. Phoenix
Sponsor: Pfizer
Sex: Female·Age: 18+
Code: NCT06952660·Phase 4·Recruiting
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
for Breast Cancer
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT06954337·Recruiting
Two Versus One Week Breast Radiotherapy (RT)
for Breast Cancer
3 locations incl. New York
Sponsor: Weill Medical College of Cornell University
Sex: Female·Age: All ages
Code: NCT06960707·Phase 3·Recruiting
Validation of Effectiveness on NaturalCycles Users
for Contraception
1 location in New York
Sponsor: Natural Cycles
Sex: Female·Age: 18 - 35
Code: NCT07566793·Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for Breast Cancer
51 locations incl. Phoenix
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06790693·Phase 3·Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for Ovarian Cancer
30 locations incl. Birmingham
Sponsor: Merck Sharp & Dohme LLC
Sex: Female·Age: 18+
Code: NCT06824467·Phase 3·Recruiting
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
for Endometrial Cancer
Drug: Ivonescimab
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female·Age: 18+
Code: NCT06925724·Phase 2·Recruiting
A Study of PHST001 in Advanced Solid Tumors
for Advanced Solid Tumors
20 locations incl. Beverly Hills
Sponsor: Pheast Therapeutics
Sex: All·Age: 18+
Code: NCT06840886·Phase 1·Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for Endometrial Cancer
Drug: Rilvegostomig
60 locations incl. Tucson
Sponsor: AstraZeneca
Sex: Female·Age: 18+
Code: NCT06989112·Phase 3·Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for Ovarian Cancer
Drug: Bevacizumab
28 locations incl. La Jolla
Sponsor: Daiichi Sankyo
Sex: Female·Age: 18+
Code: NCT06819007·Phase 3·Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for Fallopian Tube Endometrioid Adenocarcinoma
Drug: Bevacizumab
658 locations incl. Birmingham
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06580314·Phase 3·Recruiting
Brodalumab in the Treatment of Immune-Related Adverse Events
for Breast Cancer
1 location in New York
Sponsor: Brian Henick, MD
Sex: All·Age: 18+
Code: NCT06673329·Phase 1·Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for Advanced Solid Tumor
21 locations incl. Scottsdale
Sponsor: Clasp Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06778863·Phase 1·Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
for Breast Cancer
17 locations incl. Prescott
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06695845·Phase 2·Recruiting
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
for Breast Cancer
3 locations incl. Los Angeles
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT06780176·Recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer
for Endometrial Cancer
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female·Age: 18+
Code: NCT06751589·EARLY_Phase 1·Recruiting
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for Endometrial Cancer
18 locations incl. La Jolla
Sponsor: Faeth Therapeutics
Sex: Female·Age: 18+
Code: NCT06463028·Phase 2·Recruiting
A Study of Language Interpretation Solutions for People With Breast Cancer
for Breast Cancer
8 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT06721065·Recruiting
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
for Metastatic Breast Cancer
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT06678269·Phase 1·Recruiting
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
for Ovarian Cancer
1 location in New York
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: Female·Age: 18+
Code: NCT06040970·Phase 1, Phase 2·Recruiting
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
for Hypertensive Disorders of Pregnancy
16 locations incl. Birmingham
Sponsor: Ohio State University
Sex: Female·Age: 14 - 35
Code: NCT06468202·Phase 4·Recruiting
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
for Mesothelin Positive
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT06623396·Phase 1·Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
165 locations incl. Daphne
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
for Breast Cancer
1 location in New York
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female·Age: 18+
Code: NCT06127979·Recruiting
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
for Ovarian Cancer
10 locations incl. Los Angeles
Sponsor: Nammi Therapeutics Inc
Sex: All·Age: 18+
Code: NCT06582017·Phase 1·Recruiting
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
for Breast Cancer
7 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT06557148·Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
for Platinum-resistant Ovarian Cancer
13 locations incl. Little Rock
Sponsor: Context Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT06515613·Phase 1·Recruiting
Different Medications to Induce Labor
for Pregnancy
2 locations incl. New York
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: Female·Age: 18+
Code: NCT06259097·Phase 3·Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for Metastatic Solid Tumor
Drug: LY4052031
17 locations incl. Duarte
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06465069·Phase 1·Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
for Ovarian Cancer
7 locations incl. Birmingham
Sponsor: Tubulis GmbH
Sex: All·Age: 18+
Code: NCT06303505·Phase 1, Phase 2·Recruiting
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
for Ovarian Cancer
6 locations incl. Phoenix
Sponsor: NX Development Corp
Sex: Female·Age: 18+
Code: NCT05804370·Phase 3·Recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
for Breast Neoplasms
82 locations incl. Tucson
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT06157892·Phase 2·Recruiting
Vaginal Ecosystem and Network in the United States Study
for Bacterial Vaginosis
20 locations incl. Fullerton
Sponsor: Vaginal Biome Science
Sex: Female·Age: 18 - 89·Accepts healthy volunteers
Code: NCT06472765·Enrolling By Invitation
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
for Advanced or Metastatic Solid Tumors
14 locations incl. Phoenix
Sponsor: 858 Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06395519·Phase 1, Phase 2·Recruiting